S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

CardioComm Solutions Stock Forecast, Price & News

+0.01 (+16.67 %)
(As of 10/15/2021 10:53 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume56,000 shs
Average Volume145,817 shs
Market CapitalizationC$5.26 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EKG News and Ratings via Email

Sign-up to receive the latest news and ratings for CardioComm Solutions and its competitors with MarketBeat's FREE daily newsletter.

About CardioComm Solutions

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company's technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals, and call centers to access and manage patient information. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring, an ECG reading service. Additionally, the company provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.


See More Headlines

Industry, Sector and Symbol

Health Information Services
Year Founded

Sales & Book Value

Annual Sales
Cash Flow
C$0.00 per share
Book Value
C$0.00 per share





Market Cap
C$5.26 million
Next Earnings Date
Not Optionable


Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

CardioComm Solutions (CVE:EKG) Frequently Asked Questions

What stocks does MarketBeat like better than CardioComm Solutions?

Wall Street analysts have given CardioComm Solutions a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CardioComm Solutions wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has CardioComm Solutions' stock price been impacted by COVID-19?

CardioComm Solutions' stock was trading at C$0.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EKG stock has decreased by 12.5% and is now trading at C$0.04.
View which stocks have been most impacted by COVID-19

Who are CardioComm Solutions' key executives?

CardioComm Solutions' management team includes the following people:
  • Mr. Etienne Grima, CEO, Corp. Sec. & Director
  • Mr. Simi Grosman, Independent Consultant & Director
  • Ms. Josee Bertrand, Chief Financial Officer

What is CardioComm Solutions' stock symbol?

CardioComm Solutions trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EKG."

How do I buy shares of CardioComm Solutions?

Shares of EKG and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is CardioComm Solutions' stock price today?

One share of EKG stock can currently be purchased for approximately C$0.04.

How much money does CardioComm Solutions make?

CardioComm Solutions has a market capitalization of C$5.26 million and generates C$745,912.00 in revenue each year.

What is CardioComm Solutions' official website?

The official website for CardioComm Solutions is www.cardiocommsolutions.com.

Where are CardioComm Solutions' headquarters?

CardioComm Solutions is headquartered at 259 Yorkland Rd 2nd Floor, NORTH YORK, ON M2J 0B5, Canada.

How can I contact CardioComm Solutions?

CardioComm Solutions' mailing address is 259 Yorkland Rd 2nd Floor, NORTH YORK, ON M2J 0B5, Canada. The company can be reached via phone at +1-416-9779425.

This page was last updated on 10/16/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.